Michael J. Keating

Statistics

Publications

Citations

529

H-Index

Active since

1989

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Michael J. Keating is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, chemotherapy, and hematologic oncology.

Publications per year

1989–2009

Publications

Leukapheresis Reduces Early Mortality in Patients with Acute Myeloid Leukemia with High White Cell Counts But Does Not Improve Long Term Survival

Francis J. Giles, Yu Shen, Hagop M. Kantarjian et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2001 · 146 citations

Medicine, Oncology, Cell Therapy +9

The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.

Steven M. Kornblau, Peter F. Thall, Zeev Estrov et al. · PubMed · 1999 · 86 citations

Medicine, Hematology, Oncology +15

Effects of low doses of recombinant human granulocyte‐macrophage colony stimulating factor (GM‐CSF) in patients with myelodysplastic syndromes

Elihu H. Estey, Razelle Kurzrock, Moshe Talpaz et al. · British Journal of Haematology · 1991 · 76 citations

Medicine, Hematology, Pharmacotherapy +10

Acute lymphocytic leukaemia in the elderly: characteristics and outsome with the vincristine‐adriamycin‐dexamethasone (VAD) regimen

Hagop M. Kantarjian, Susan O’Brien, Terry Smith et al. · British Journal of Haematology · 1994 · 64 citations

Medicine, Geriatric Medicine, Oncology +9

Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia

Hagop M. Kantarjian, Michael J. Keating, Ronald S. Walters et al. · Cancer · 1989 · 54 citations

Medicine, Hematology, Pharmacology +17

1–5 of 9